Literature DB >> 32900625

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.

Roy Mano1, Cihan Duzgol2, Maz Ganat3, Debra A Goldman4, Kyle A Blum5, Andrew W Silagy6, Aleksandra Walasek7, Alejandro Sanchez8, Renzo G DiNatale7, Julian Marcon9, Mahyar Kashan10, Maria F Becerra11, Nicole Benfante7, Jonathan A Coleman7, Michael W Kattan12, Paul Russo7, Oguz Akin2, Irina Ostrovnaya13, A Ari Hakimi14.   

Abstract

OBJECTIVES: Preoperative models, based on patient and tumor characteristics, predict risk for adverse outcomes after nephrectomy. Changes in renal tumor characteristics over the last decades, warrant further evaluation using contemporary cohorts. We aimed to validate a previously published preoperative nomogram predicting 12-year metastasis-free probability after nephrectomy for localized renal tumors in a contemporary cohort. PATIENTS AND METHODS: After obtaining institutional review board approval, data of 1,760 patients who underwent nephrectomy for a localized renal mass between 2005 and 2011 were reviewed. Preoperative images were evaluated for the presence of tumor necrosis, lymphadenopathy, and tumor size. The study outcome was metastatic-free probability. Model discrimination was assessed with Gönen and Heller's concordance probability estimate, and calibration was evaluated.
RESULTS: The cohort included 1,102 male and 658 female patients with a median age of 60 years. Most patients presented incidentally (84%). On imaging, 3% had evidence of lymphadenopathy, 55% had necrosis and median tumor diameter was 3.7 cm (interquartile range [IQR]: 2.5, 5.5). Median follow-up in non-metastatic patients was 7.7 years (IQR: 5.3, 9.7). Estimated 12-year metastatic-free probability was 88% (86%-90%). The model showed strong discrimination (concordance probability estimate [CPE]: 0.77), and fair calibration. The time-dependent receiver operating characteristic (ROC) curves showed strong discrimination at all-time points and the area under the curve (AUC) for year 12 was 0.83 (95% Confidence Interval: 0.78-0.89).
CONCLUSIONS: We validated the preoperative nomogram of 12-year metastasis-free probability in a contemporary cohort despite different tumor characteristics. Future studies should evaluate the role of preoperative risk stratification in patient selection for neoadjuvant treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metastases; Nephrectomy; Nomogram; Outcome; Preoperative; Renal cell carcinoma

Year:  2020        PMID: 32900625      PMCID: PMC7607679          DOI: 10.1016/j.urolonc.2020.07.019

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  1 in total

1.  Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.

Authors:  Maria I Carlo; Kyrollis Attalla; Yousef Mazaheri; Sounak Gupta; Onur Yildirim; Samuel J Murray; Devyn T Coskey; Ritesh Kotecha; Chung-Han Lee; Darren R Feldman; Paul Russo; Sujata Patil; Robert J Motzer; Jonathan A Coleman; Jeremy C Durack; Ying-Bei Chen; Oguz Akin; A Ari Hakimi; Martin H Voss
Journal:  Eur Urol       Date:  2022-02-17       Impact factor: 24.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.